Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Intern Med ; 59(2): 247-252, 2020.
Article in English | MEDLINE | ID: mdl-31941871

ABSTRACT

Studies reporting chest images of respiratory syncytial virus (RSV)-induced lower respiratory tract infection (LRTI) in an outbreak setting and their relationship to the clinical manifestation are limited. During a genetically confirmed RSV outbreak, eight patients underwent both chest X-ray and computed tomography (CT). Among these, 5 cases had newly appearing abnormalities on CT, although chest X-ray was able to detect abnormalities in only 2 cases (40%). Although bronchial wall thickening was common, other findings and their distribution were variable, even in an outbreak setting. All patients with both a history of anticancer chemotherapy against hematological cancer and lower respiratory symptoms, such as wheezing, sputum, and hypoxemia, had abnormalities on CT, suggesting that these two factors might be important for predicting the existence of LRTI in RSV-infected patients.


Subject(s)
Respiratory Syncytial Virus Infections/diagnostic imaging , Respiratory Tract Infections/diagnostic imaging , Aged , Disease Outbreaks , Humans , Japan/epidemiology , Middle Aged , Respiratory Sounds , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Tract Infections/epidemiology , Retrospective Studies , Tomography, X-Ray Computed/methods , Young Adult
2.
Int J Mycobacteriol ; 6(4): 336-343, 2017.
Article in English | MEDLINE | ID: mdl-29171446

ABSTRACT

Sweet's syndrome is reportedly associated with preceding nontuberculous mycobacterial infections (NTMIs). Here, we report on a systemic Mycobacterium intracellulare infection in a patient on corticoid therapy for Sweet's syndrome. Literature searches show that 69.1% of patients with Sweet's syndrome and NTMIs developed this syndrome later than NTMIs and 89.3% of them developed during the clinical course of a rapidly growing mycobacterial infection. The residual cases were associated with slow-growing mycobacteria (14.3%), but only three cases of Mycobacterium avium complex (MAC) infections before the onset of Sweet's syndrome have been reported, and all of them were caused by disseminated MAC disease. One of these cases developed during corticoid therapy for Sweet's syndrome, while another case had underlying diabetes mellitus. Hence, the occurrence of systemic MAC disease may be an inevitable consequence of long-term steroid use and underlying diseases. Literature searches also show that cervical lymphadenitis was a predominant symptom in NTMIs (90.5%). The present case did not have cervical lymphadenitis although the previously reported MAC cases did experience it. Therefore, lymphadenitis from NTMIs may be related to the pathogenesis of Sweet's syndrome. Hence, should a patient have systemic infection without lymphadenitis, it will be more difficult to clinically confirm that MAC disease is a predisposing factor for Sweet's syndrome.


Subject(s)
Glucocorticoids/adverse effects , Mycobacterium avium Complex/physiology , Mycobacterium avium-intracellulare Infection/complications , Sweet Syndrome/etiology , T-Lymphocytes, Helper-Inducer/immunology , Aged , Anti-Bacterial Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Drug Therapy, Combination , Glucocorticoids/therapeutic use , Humans , Immunocompromised Host , Lymphadenitis/etiology , Male , Mycobacterium avium Complex/growth & development , Mycobacterium avium-intracellulare Infection/diagnosis , Mycobacterium avium-intracellulare Infection/drug therapy , Sweet Syndrome/diagnosis , Sweet Syndrome/drug therapy , T-Lymphocytes, Helper-Inducer/classification , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL